Custom Antibody Market Size Driven by Growth in Pharmaceutical Sector
Custom Antibody Market Highlights:
Custom Antibody Market size report has valued the industry size at USD 0.16 billion in 2022. The custom antibody market industry is projected to grow from USD 0.17 Billion in 2023 to USD 0.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.8% during the forecast period (2023 - 2030).
The Custom Antibody Market stands out in the dynamic environment of life sciences as a marvel of personalised precision, paving the route to significant scientific discovery. Custom antibodies, which are meticulously tailored to reveal the secrets of proteins and biomolecules, have emerged as indispensable tools in modern biotechnology. This market's brilliance is powered by an insatiable desire for personalised medicine, an increase in focused medicines, and an unwavering pursuit of unravelling complex diseases. Custom antibodies emerge as reliable companions as researchers start on journeys to unravel the mysteries of cancer, autoimmune disorders, and infectious diseases. These custom-made antibodies exemplify the essence of scientific innovation, providing a glimpse into the seemingly unlimited potential of healthcare customization and, as a result, irrevocably altering the trajectory of medical progress.
Segmentation:
The Global Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users. On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labelling. The antibody development is segmented into antibody characterization, antigen preparation, immunization & hybridoma production. On the basis of source, the market has been classified as mice, rabbits, human beings and others. On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others. On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas. On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.
Regional Analysis:
The Americas is projected to lead the custom antibody market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market. Also, growing investments in the progress of structure-based drug designs, growing focus on developing antibody-based therapeutics, rising research in the fields of genomics field, increasing demand for good quality research tools for data reproducibility and the existence of a huge number of global players in this region.
The European market is expected to hold the second largest market share. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. According to the Parkinson’s news today, the frequency of Parkinson’s disease in the U.K. is about 1 in 500 people, with a total of about 127,000 people living with the disease. According to Capra Science, a European company specialized in custom antibody production, llama-derived nanobodies might find therapeutic application in Parkinson’s disease.
Asia-Pacific is projected to be the fastest growing region for the global custom antibody. It is expected to witness profitable growth over the forecast period due to the existence of favorable healthcare schemes drafted by government agencies and growing research activities in the field of mAb-based therapeutics. Awareness programs and quality assurance of diagnostic procedures have added importance in the developing economies of Korea, Taiwan, China, Sri Lanka and India since the last few years.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Key Players:
Some of the key players in the custom antibody market overview report are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian